Lithium ascorbate as a cerebroprotective agent in a model of ischemic stroke

Plotnikov E.V.; Litvak M.M.

doi:https://doi.org/10.17116/jnevro202012003229

Plotnikov E.V.

National Research Tomsk Polytechnic University, Research School of Chemical and Biomedical Technologies, Tomsk, Russia

Litvak M.M.

National Research Tomsk Polytechnic University, Research School of Chemical and Biomedical Technologies, Tomsk, Russia

Lithium ascorbate as a cerebroprotective agent in a model of ischemic stroke

Authors:

Plotnikov E.V., Litvak M.M.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(3‑2): 29‑32

DOI: 10.17116/jnevro202012003229

Read: 4664 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Plotnikov EV, Litvak MM. Lithium ascorbate as a cerebroprotective agent in a model of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(3‑2):29‑32. (In Russ.)
https://doi.org/10.17116/jnevro202012003229

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Connectome in stroke patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):46-50

Neurocytoprotection advances in reperfusion therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):75-88

Asthenia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):5-10

Effectiveness of comprehensive rehabilitation of patients after a stroke in terms of changes in clinical and functional characteristics. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):11-16

Methods for determining the extent of ischemic changes in brain matter in the prognosis of clinical outcome after successful thromboextraction. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):17-27

Fibrin monomer in diagnosis of cardiovascular diseases. Russian Cardiology Bulletin. 2024;(4-2):113-120

Analysis of risk factors associated with ischemic stroke in the setting of Ph-negative myeloproliferative diseases. Russian Journal of Preventive Medicine. 2025;(1):50-56

Neuroprotective therapy of glaucoma. Russian Annals of Ophthalmology. 2025;(1):83-90

Cognitive vascular disorders and morphometric parameters of the prefrontal, dorsolateral cortex and thalamus in post-stroke patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):91-95

Prevalence of cerebrovascular diseases risk factors according to the cohort survey data in Bishkek, Kyrgyz Republic. Russian Journal of Preventive Medicine. 2025;(3):34-39

Abstract:

Introduction. Ischemic stroke is one of the most severe neurological pathologies with high mortality and disability. In this connection, the development and study of new drugs for the prevention and treatment of stroke is an extremely important task. A new approach to neuroprotection is the use of lithium salts with antioxidant activity. Objective. To study the cerebroprotective effect of lithium ascorbate on a rat model of ischemic stroke. Material and methods. Test samples of lithium ascorbate were synthesized ex tempore for an experiment using reagents of ACS qualification (Sigma-Aldrich). The ischemic stroke model was realized using the filament occlusion of the middle cerebral artery in rats of the Sprague Dawley line according to standardized procedure. Neurological examination of the animals, histological study of brain tissue with staining of brain sections, and calculating the volume of cerebral infarction were performed. Results and Conclusion. There is a significant cerebroprotective effect of lithium ascorbate expressed in a multiple decrease in the volume of the zone of cerebral infarction (by 75% of the control group indicator) and the absence of mortality in the experimental group of animals. Newly discovered distinct anti-stroke effect of lithium ascorbate in combination with low toxicity could be considered promising for further clinical studies and practical application in neurology.

Keywords:

lithium ascorbate

stroke

cerebroprotective effect

neuroprotection

filament occlusion

ischemia

Authors:

Plotnikov E.V.

National Research Tomsk Polytechnic University, Research School of Chemical and Biomedical Technologies, Tomsk, Russia

Litvak M.M.

National Research Tomsk Polytechnic University, Research School of Chemical and Biomedical Technologies, Tomsk, Russia

Close metadata

References:

Yakhno NN, Vilensky BS. Stroke as a medical and social problem. Russkiy Meditsinskiy Zhurnal. 2005;13(12):807-815. (In Russ.)
Bonita R, Mendis S, Truelsen T, Bogousslavsky J, Toole J, Yatsu F. The global stroke initiative. Lancet Neurology. 2004;3(7):391-393. https://doi.org/10.1016/s1474-4422(04)00800-2
Shamalov NA, Shetova IM. Combined cytoprotection in the treatment of cerebrovascular accidents. Effektivnaya Farmakoterapiya. 2011;3:12-14. (In Russ.)
Yang J. The role of reactive oxygen species in angiogenesis and preventing tissue injury after brain ischemia (Review). Microvascular Research. 2019;123:62-67. https://doi.org/10.1016/j.mvr.2018.12.005
Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ. Role of IL-1α and IL-1β in ischemic brain damage. Journal of Neuroscience. 2001;21(15):5528-5534. https://doi.org/10.1523/jneurosci.21-15-05528.2001
Plotnikov MB, Chernysheva GA, Aliev OI, Smol’iakova VI, Fomina TI, Osipenko AN, Rydchenko VS, Anfinogenova YJ, Khlebnikov AI, Schepetkin IA, Atochin DN. Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats. Molecules. 2019;24(9):1722. https://doi.org/10.3390/molecules24091722
Zhang Z, Yang J-L, Zhang L-L, Chen Z-Z, Chen J-O, Cao Y-G, Qu M, Lin X-D, Ji X-M, Han Z. 2-(2-Benzofuranyl)-2-imidazoline treatment within 5 hours after cerebral ischemia/reperfusion protects the brain. Neural Regeneration Research. 2018;13(12):2111-2118. https://doi.org/10.4103/1673-5374.241461
Mashkovsky MD. Medicines. in two parts. P. 1. 12th ed., Revised. and add. M.: Medicine; 1986. (In Russ.)
Ren M, Senatorov V, Chen R, Chuang D. Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model. Proceedings of the National Academy of Sciences. 2003;100(10):6210-6215. https://doi.org/10.1073/pnas.0937423100
Moroz VV, Silachev DN, Plotnikov EYu, Zorova LD, Pevzner IB, Grebenchikov OA, Likhvantsev VV. Mechanisms of cell damage and protection during ischemia/reperfusion and experimental justification for the use of lithium-based drugs in anesthesiology. Obshchaya Reanimatologiya. 2013;11(1):63-71. (In Russ.) https://doi.org/10.15360/1813-9779-2013-1-63
Sun YR, Herrmann N, Scott CJM, Black SE, Swartz RH, Hopyan J, Lanctot KL. Lithium carbonate in a poststroke population: exploratory analyses of neuroanatomical and cognitive outcomes. Journal of Clinical Psychopharmacology. 2019;39(1):67-71. https://doi.org/10.1097/jcp.0000000000000981
Balashov PP, Anikina EYu, Plotnikov EV, Potapov AV, Chuchalin VS. Comparative study of the neurotoxic effect of lithium salts. Sibirskiy Vestnik Psikhiatrii i Narkologii. 2008;4(51):84. (In Russ.)
Plotnikov E, Korotkova E, Voronova O, Dorozhko E, Bohan N, Plotnikov S. Lithium-based antioxidants: electrochemical properties and influence on immune cells. Physiology and Pharmacology. 2015;19(2):107-113. http://phypha.ir/ppj/article-1-1098-en.html
Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema, a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Japanese Journal of Stroke. 1986;8:1-8. https://doi.org/10.3995/jstroke.8.1
Plotnikov E, Losenkov I, Epimakhova E, Bohan N. Protective effects of pyruvic acid salt against lithium toxicity and oxidative damage in human blood mononuclear cells. Advanced Pharmaceutical Bulletin. 2019;9(2):302-306. https://doi.org/10.15171/apb.2019.035
Losenkov IS, Plotnikov EV, Epimakhova EV. Cytotoxic and prooxidant effects of lithium ascorbate in vitro. Sibirskiy Vestnik Psikhiatrii i Narkologii. 2018;1(98):24-29. (In Russ.) https://doi.org/10.26617/1810-3111-2018-1(98)-24-29
Xu H, Gu H, Yang Y, Cai E, Ding F, Yu S. 2-(4-Methoxyphenyl)Ethyl-2-Acetamido-2-Deoxy-β-D-Pyranoside exerts a neuroprotective effect through regulation of energy homeostasis and O-GlcNAcylation. Journal of Molecular Neuroscience. 2019;69(2):177-187. https://doi.org/10.1007/s12031-019-01347-3